EGFR exon 20 insertions in non-small cell lung cancer (NSCLC): Impact of co-occurring mutations and immune checkpoint blockade (ICB)

被引：0

作者：

Kron, A. ^{[1
]}

Scheffler, M. ^{[1
]}

Ihle, M. ^{[2
]}

Michels, S. ^{[1
]}

Sueptitz, J. ^{[1
]}

Prang, D. ^{[1
]}

Jakobs, F. ^{[3
]}

Nogova, L. ^{[1
]}

Fischer, R. ^{[1
]}

Grohe, C. ^{[4
]}

Kaminsky, B. ^{[5
]}

Benedikter, J. ^{[6
]}

Ladage, D. ^{[7
]}

Brummendorf, T. ^{[8
]}

Krueger, S. ^{[9
]}

Eisert, A. ^{[1
]}

Riedel, R. ^{[1
]}

Kron, F. ^{[10
]}

Hillmer, A.

Loges, S. ^{[11
]}

Merkelbach-Bruse, S. ^{[2
]}

Buettner, R. ^{[2
]}

Wolf, J. ^{[1
]}

机构：

[1] Uniklin Koln, Innere Med Klin 1, Cologne, Germany

[2] Uniklin Koln, Inst Pathol, Cologne, Germany

[3] Uniklin Essen, Klin Hamatol & Stammzelltransplantat, Essen, Germany

[4] Evangel Lungenklin, Berlin, Germany

[5] Krankenhaus Bethanien Solingen, Solingen, Germany

[6] Munchen Klin Bogenhausen, Munich, Germany

[7] Klin Maria Hilf GmbH, Monchengladbach, Germany

[8] Uniklin RTWH Aachen, Klin Onkol, Hamatol & Stammzelltransplantat Med Klin 4, Aachen, Germany

[9] Florence Nightingale Krankenhaus Kaiserswerther, Pneumol Kardiol & Internist Intens Med, Dusseldorf, Germany

[10] FOM Hsch, Cologne, Germany

[11] Univ Med Mannheim, DKFZ, Mannheim, Germany

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2022年 / 45卷 / SUPPL 2期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

V903

引用

页码：271 / 271

页数：1

共 50 条

[1] EGFR exon 20 insertions in non-small cell lung cancer (NSCLC): Impact of TP53 mutation status and value of immune checkpoint blockade (ICB)
Kron, A.
Scheffler, M.
Ihle, M.
Michels, S.
Sueptitz, J.
Prang, D.
Jakobs, F.
Nogova, L.
Fischer, R. N.
Eisert, A. K.
Riedel, R.
Kron, F.
Hillmer, A.
Loges, S.
Merkelbach-Bruse, S.
Buettner, R.
Wolf, J.
ANNALS OF ONCOLOGY, 2022, 33 (07) : S1006 - S1006
[2] Sensitivity to Immune Checkpoint Blockade in Advanced Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations
Metro, Giulio
Baglivo, Sara
Bellezza, Guido
Mandarano, Martina
Gili, Alessio
Marchetti, Giovanni
Toraldo, Marco
Molica, Carmen
Reda, Maria Sole
Tofanetti, Francesca Romana
Siggillino, Annamaria
Prosperi, Enrico
Giglietti, Antonella
Di Girolamo, Bruna
Garaffa, Miriam
Marasciulo, Francesca
Minotti, Vincenzo
Gunnellini, Marco
Guida, Annalisa
Sassi, Monica
Sidoni, Angelo
Roila, Fausto
Ludovini, Vienna
GENES, 2021, 12 (05)
[3] Amivantamab with chemotherapy - Non-small cell lung cancer with EGFR exon 20 insertions
Drappier, Noemie
Pierret, Thomas
BULLETIN DU CANCER, 2024, 111 (12) : 1085 - 1087
[4] EGFR exon 20 insertion mutations in non-small cell lung cancer
Wang, Fenfang
Li, Chenghui
Wu, Qihuan
Lu, Hongyang
TRANSLATIONAL CANCER RESEARCH, 2020, 9 (04) : 2982 - 2991
[5] Spectrum of EGFR Exon 20 Insertion Mutations and Co-Occurring Genetic Alterations in Patients with Non-Small-Cell Lung Cancer
Montenegro, G. Bravo
Nagasaka, M.
Ma, P.
Naqash, A. R.
Mamdani, H.
Spira, A.
Subramaniam, D.
Feldman, R.
Kim, C.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S680 - S680
[6] Association of EGFR and HER-2 exon 20 mutations with distinct patterns of response to immune checkpoint blockade in non-small cell lung cancer.
Negrao, Marcelo Vailati
Reuben, Alexandre
Robichaux, Jacqulyne Ponville
Le, Xiuning
Nilsson, Monique B.
Wu, Chang-jiun
Zhang, Jianhua
Landry, Lara C. A.
Roarty, Emily
Rinsurongkawong, Waree
Swisher, Stephen
Simon, George R.
Futreal, Andrew
Glisson, Bonnie S.
Zhang, Jianjun
Heymach, John
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[7] Immune checkpoint blockade (ICB) for first line treatment in non-small-cell lung cancer (NSCLC)
Rosell, Rafael
Karachaliou, Niki
Sosa, Aaron
Viteri, Santiago
TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S408 - S410
[8] Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
Simon Vyse
Paul H. Huang
Signal Transduction and Targeted Therapy, 4
[9] Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
Vyse, Simon
Huang, Paul H.
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2019, 4 (1)
[10] Clinical characteristics of advanced non-small cell lung cancer patients with EGFR exon 20 insertions
Morita, Chie
Yoshida, Tatsuya
Shirasawa, Masayuki
Masuda, Ken
Matsumoto, Yuji
Shinno, Yuki
Yagishita, Shigehiro
Okuma, Yusuke
Goto, Yasushi
Horinouchi, Hidehito
Yamamoto, Noboru
Motoi, Noriko
Yatabe, Yasushi
Ohe, Yuichiro
SCIENTIFIC REPORTS, 2021, 11 (01)

← 1 2 3 4 5 →